Dr. Jena Rene Pizula, MD

Dr. Pizula practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Pizula's NPI, 1326401621, was assigned on April 4, 2016. Dr. Pizula graduated from Keck School of Medicine of USC in 2016. Dr. Pizula holds California license A152361.

Dr. Pizula's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Pizula's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Pizula is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Pizula to 3 more hospitals and 1 medical group, each named with a free account. Dr. Pizula's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pizula practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Pizula's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Pizula is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Pizula is licensed in California.

Dmand AI lists atrial fibrillation and flutter, coronary artery disease and high cholesterol among the conditions Dr. Pizula treats.

CMS data shows 895 Medicare services from Dr. Pizula across 15 procedure codes in 2024, for 565 Medicare patients. Medicare paid $66,937 for them.

CMS counts 565 Medicare patients who saw Dr. Pizula in 2024. The largest group is 75 to 84, with 220 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pizula's median patient age at 59, with 57% women.

In 2024, Dr. Pizula wrote 1,145 Medicare Part D claims for 178 patients. 79% of them were for generic drugs. CMS names the drug for 926 of them, across 21 drugs with 11 or more claims each, at $233,278 in total drug cost. In 2023, CMS named 97 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Pizula for performance year 2024, reported as part of a group. Dr. Pizula accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pizula as offering telehealth.

Dmand AI links 3 papers to Dr. Pizula, published from 2022 to 2025. 2025 was the busiest year, with 2. Dr. Pizula's most frequent co-authors are Uri Elkayam, MD, Justin Lim Devera and Ryan Kabir, MD.

CMS Open Payments shows 36 general payments to Dr. Pizula from 18 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 91% of the total. Boston Scientific Corporation paid the most, $635.

Dr. Pizula graduated from Keck School of Medicine of USC in 2016. Dr. Pizula is a member of AAP, AHA and AMA.

Dr. Pizula is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.